Skip to main content
. 2023 Sep 18;14:1231933. doi: 10.3389/fphar.2023.1231933

TABLE 4.

Association of TCM treatment duration with the prognosis of patients with primary liver cancer after GBM weighted.

Variable Beta HR (95% CI) P
Time-to-treatment
3 months ∼ 6months −0.356 0.701 (0.446–1.101) 0.1226
6 months ∼ 12 months −0.799 0.450 (0.269–0.751) 0.0023
>12 months −1.357 0.257 (0.146–0.452) <0.001
HHS Vulnerability Disclosure